Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (761-770 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?Flora H Duits, Charlotte E Teunissen, Femke H Bouwman, et al.
Neurobiology of Aging|March 12, 2014
No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathyMeinie Seelen, Anne E Visser, Daniel J Overste, et al.
Nature Reviews. Neurology|March 1, 2024
Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsJoseph Therriault, Suzanne E Schindler, Gemma Salvadó, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 2021
Kinetics and 28-day test-retest repeatability and reproducibility of [<sup>11</sup>C]UCB-J PET brain imagingHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Research Square|August 7, 2024
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 4, 2021
LDL cholesterol and uridine levels in blood are potential nutritional biomarkers for clinical progression in Alzheimer's disease: The NUDAD projectFrancisca A de Leeuw, Betty M Tijms, Astrid S Doorduijn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 1, 2013
Shining a light on posterior cortical atrophySebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 16, 2022
Effects of age, amyloid, sex, and <i>APOE</i> ε4 on the CSF proteome in normal cognitionKirsten E J Wesenhagen, Johan Gobom, Isabelle Bos, et al.
JAMA Network Open|January 13, 2023
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive DeclineCamilla Caprioglio, Federica Ribaldi, Leonie N C Visser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotypeLisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
Pageof 91

Showing results (761-770 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?Flora H Duits, Charlotte E Teunissen, Femke H Bouwman, et al.
Neurobiology of Aging|March 12, 2014
No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathyMeinie Seelen, Anne E Visser, Daniel J Overste, et al.
Nature Reviews. Neurology|March 1, 2024
Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsJoseph Therriault, Suzanne E Schindler, Gemma Salvadó, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 2021
Kinetics and 28-day test-retest repeatability and reproducibility of [<sup>11</sup>C]UCB-J PET brain imagingHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Research Square|August 7, 2024
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 4, 2021
LDL cholesterol and uridine levels in blood are potential nutritional biomarkers for clinical progression in Alzheimer's disease: The NUDAD projectFrancisca A de Leeuw, Betty M Tijms, Astrid S Doorduijn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 1, 2013
Shining a light on posterior cortical atrophySebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 16, 2022
Effects of age, amyloid, sex, and <i>APOE</i> ε4 on the CSF proteome in normal cognitionKirsten E J Wesenhagen, Johan Gobom, Isabelle Bos, et al.
JAMA Network Open|January 13, 2023
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive DeclineCamilla Caprioglio, Federica Ribaldi, Leonie N C Visser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotypeLisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
Pageof 91